Verana Health, Inc.

Verana Health is a digital health company that leverages real-world data (RWD) and artificial intelligence (AI) to accelerate healthcare innovation and optimize drug and device development. The company's mission is to empower clinical researchers, life science analysts, and clinicians with data-driven insights to advance medical research. Headquartered in San Francisco, California, Verana Health utilizes physician expertise and advanced technology to unlock the potential of RWD. [1, 2, 3, 8, 10, 12, 13, 23, 26]

Verana Health offers a data insights platform, research services, and advanced analytics platforms. Key offerings include "Qdata," which are disease-specific, research-ready data modules, powered by "VeraQ," a population health data engine. The company also provides solutions for clinical trials, such as Site Explorer and Verana Trial Connect, and supports clinicians with quality reporting services like MIPS. Verana Health serves life sciences companies, contract research organizations (CROs), healthcare providers, and specialty medical societies, drawing from an exclusive real-world data network of over 20,000 clinicians and more than 90 million de-identified patients across ophthalmology, urology, neurology, and oncology. [2, 3, 15, 16, 18, 20, 24, 27, 28]

In a significant development, Verana Health merged with COTA, Inc. on January 8, 2026, to expand its oncology offerings and enhance its real-world data capabilities. This merger broadened the company's patient access and client base, now serving 17 of the top 20 global biopharma companies. Sujay Jadhav leads the company as CEO. Verana Health is recognized as a leader in real-world evidence solutions, leveraging AI and machine learning technology, and has secured substantial funding, including a $150 million Series E round in January 2022, contributing to a total funding exceeding $360 million. [1, 3, 7, 9, 11, 15, 16, 17, 18, 19, 21, 23, 25, 26, 28]